Depression and anxiety affect biological processes of cardiovascular function in patients with heart failure by altering neurohormonal function, autonomic dysregulation, and cytokine cascades.
Depression and anxiety share underlying pathophysiological mechanisms with heart failure, including neurohormonal activation and autonomic dysregulation, which may contribute to disease progression.
Depression and anxiety are common comorbid conditions in patients with heart failure. Patients with heart failure and depression have increased mortality. The association of anxiety with increased mortality in patients with heart failure is not established. The purpose of this article is to illustrate the similarities of the underlying pathophysiology of heart failure, depression, and anxiety by using the Biopsychosocial Holistic Model of Cardiovascular Health. Depression and anxiety affect biological processes of cardiovascular function in patients with heart failure by altering neurohormonal function via activation of the hypothalamic-pituitary-adrenal axis, autonomic dysregulation, and activation of cytokine cascades and platelets. Patients with heart failure and depression or anxiety may exhibit a continued cycle of heart failure progression, increased depression, and increased anxiety. Understanding the underlying pathophysiological relationships in patients with heart failure who experience comorbid depression and/or anxiety is critical in order to implement appropriate treatments, educate patients and caregivers, and educate other health professionals.
Chapa et al. (Tue,) conducted a review in Heart failure, depression, and anxiety. Depression and anxiety affect biological processes of cardiovascular function in patients with heart failure by altering neurohormonal function, autonomic dysregulation, and cytokine cascades.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: